1
3
4
News & Events
InterVenn Biosciences to make Malaysia its regional hub
August 3, 2022
Malaysia as regional hub for delivery of InterVenn's services and products in ASEAN & APAC. Read more
InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study
August 2, 2022
NICE Study is intended to validate InterVenn's platform to detect early colorectal cancers. Read more
Congenica appoints Robert Denison as CEO
June 22, 2022
Rob will also join the Board of the company. Read more
6
7
News & Events
InterVenn Biosciences to make Malaysia its regional hub
August 3, 2022
Malaysia as regional hub for delivery of InterVenn's services and products in ASEAN & APAC. Read more
InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study
August 2, 2022
NICE Study is intended to validate InterVenn's platform to detect early colorectal cancers. Read more
Congenica appoints Robert Denison as CEO
June 22, 2022
Rob will also join the Board of the company. Read more
14
Championing
collaborations
that improve health
and the quality of life
for everyone.

#JoinForces
#LifeSciencesInTheFuture
21
25
29
35
37
News & Events
InterVenn Biosciences to make Malaysia its regional hub
August 3, 2022
Malaysia as regional hub for delivery of InterVenn's services and products in ASEAN & APAC. Read more
InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study
August 2, 2022
NICE Study is intended to validate InterVenn's platform to detect early colorectal cancers. Read more
Congenica appoints Robert Denison as CEO
June 22, 2022
Rob will also join the Board of the company. Read more
39
41